Cargando…

Obstructive sleep apnea and cardiovascular risk

Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly bein...

Descripción completa

Detalles Bibliográficos
Autor principal: Dorasamy, Punginathn
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387304/
https://www.ncbi.nlm.nih.gov/pubmed/18516275
_version_ 1782155310431993856
author Dorasamy, Punginathn
author_facet Dorasamy, Punginathn
author_sort Dorasamy, Punginathn
collection PubMed
description Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and pulmonary hypertension.
format Text
id pubmed-2387304
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-23873042008-05-30 Obstructive sleep apnea and cardiovascular risk Dorasamy, Punginathn Ther Clin Risk Manag Review Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and pulmonary hypertension. Dove Medical Press 2007-12 2007-12 /pmc/articles/PMC2387304/ /pubmed/18516275 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Dorasamy, Punginathn
Obstructive sleep apnea and cardiovascular risk
title Obstructive sleep apnea and cardiovascular risk
title_full Obstructive sleep apnea and cardiovascular risk
title_fullStr Obstructive sleep apnea and cardiovascular risk
title_full_unstemmed Obstructive sleep apnea and cardiovascular risk
title_short Obstructive sleep apnea and cardiovascular risk
title_sort obstructive sleep apnea and cardiovascular risk
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387304/
https://www.ncbi.nlm.nih.gov/pubmed/18516275
work_keys_str_mv AT dorasamypunginathn obstructivesleepapneaandcardiovascularrisk